Quality of life-related outcomes from a patient-tailored integrative medicine program: experience of Russian-speaking patients with cancer in Israel

摘要: Complementary/integrative medicine (CIM) is increasingly being integrated with standard supportive cancer care. The effects of CIM on quality life (QOL) during chemotherapy need to be examined in varied socio-cultural settings. We purpose explore the impact QOL-related outcomes among Russian-speaking (RS) patients cancer. RS undergoing receiving care were eligible. Patients treatment arm seen by an integrative physician (IP) and treated within a patient-tailored program. Symptoms QOL assessed at baseline, 6, 12 weeks Edmonton Symptom Assessment Scale (ESAS), Measure Yourself Concerns Wellbeing (MYCAW) questionnaire, European Organization for Research Treatment Cancer Quality Life Questionnaire (EORTC QLQ-C30). Of 70 referred arm, 50 (71.4 %) underwent IP assessment treatments. 51 control 38 (76 %) agreed participate. At 6 weeks, CIM-treated reported improved ESAS scores fatigue (P = 0.01), depression (P = 0.048), appetite (P = 0.008), sleep (P < 0.0001), general wellbeing (P = 0.004). No improvement was observed controls. Between-group analysis found had (P = 0.019) EORTC (P = 0.007) 6 weeks. Social functioning between 6 (EORTC, P = 0.02), global health status/QOL scale from baseline P = 0.007). A program may improve chemotherapy. Integrating conventional needs address cross-cultural aspects study protocol registered ClinicalTrials.gov ( https://clinicaltrials.gov/ct2/show/NCT01860365 ).